MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/mnm.0000000000001793

Медицинская библиотека · Nuclear medicine communications · 2023

18 F-FDG PET/MRI for restaging esophageal cancer after neoadjuvant chemoradiotherapy.

Valkema Maria J, de Lussanet de la Sablonière Quido G, Valkema Roelf, Thomeer Maarten G J, Dwarkasing Roy S, Harteveld Anita A, Doukas Michail, Mostert Bianca, van der Zijden Charlène J, van der Sluis Pieter C, Lagarde Sjoerd M, Wijnhoven Bas P L, Verburg Frederik A, van Lanschot J Jan B

СтатьяПеревод пока не подготовлен

Аннотация

PURPOSE: The purpose of this study was to investigate whether 18F-fluorodeoxyglucose ( 18 F-FDG) PET/MRI may potentially improve tumor detection after neoadjuvant chemoradiotherapy (nCRT) for esophageal cancer.

METHODS

This was a prospective, single-center feasibility study. At 6-12 weeks after nCRT, patients underwent standard 18 F-FDG PET/computed tomography (CT) followed by PET/MRI, and completed a questionnaire to evaluate burden. Two teams of readers either assessed the 18 F-FDG PET/CT or the 18 F-FDG PET/MRI first; the other scan was assessed 1 month later. Maximum standardized uptake value corrected for lean body mass (SUL max ) and mean apparent diffusion coefficient (ADC mean ) were measured at the primary tumor location. Histopathology of the surgical resection specimen served as the reference standard for diagnostic accuracy calculations. When patients had a clinically complete response and continued active surveillance, response evaluations until 9 months after nCRT served as a proxy for ypT and ypN (i.e. 'ycT' and 'ycN').

RESULTS

In the 21 included patients [median age 70 (IQR 62-75), 16 males], disease recurrence was found in the primary tumor in 14 (67%) patients (of whom one ypM+, detected on both scans) and in locoregional lymph nodes in six patients (29%). Accuracy (team 1/team 2) to detect yp/ycT+ with 18 F-FDG PET/MRI vs. 18 F-FDG PET/CT was 38/57% vs. 76/61%. For ypN+, accuracy was 63/53% vs. 63/42%, resp. Neither SUL max (both scans) nor ADC mean were discriminatory for yp/ycT+ . Fourteen of 21 (67%) patients were willing to undergo a similar 18 F-FDG PET/MRI examination in the future.

CONCLUSION

18 F-FDG PET/MRI currently performs comparably to 18 F-FDG PET/CT. Improvements in the scanning protocol, increasing reader experience and performing serial scans might contribute to enhancing the accuracy of tumor detection after nCRT using 18 F-FDG PET/MRI.

TRIAL REGISTRATION: Netherlands Trial Register NL9352.

Для цитирования: Valkema Maria J, de Lussanet de la Sablonière Quido G, Valkema Roelf, Thomeer Maarten G J, Dwarkasing Roy S, Harteveld Anita A, Doukas Michail, Mostert Bianca, van der Zijden Charlène J, van der Sluis Pieter C, Lagarde Sjoerd M, Wijnhoven Bas P L, Verburg Frederik A, van Lanschot J Jan B. 18 F-FDG PET/MRI for restaging esophageal cancer after neoadjuvant chemoradiotherapy.. Nuclear medicine communications. 2023. DOI: 10.1097/mnm.0000000000001793.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.